Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: A randomized multicenter study
- 19 October 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 44 (8), 1557-1566
- https://doi.org/10.1016/j.jacc.2004.05.084
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trialThe Lancet, 2003
- Effects of low‐dose warfarin and aspirin versus no treatment on stroke in a medium‐risk patient population with atrial fibrillationJournal of Internal Medicine, 2003
- Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral InfarctionStroke, 2003
- Randomized comparative trial of triflusal and aspirin following acute myocardial infarctionEuropean Heart Journal, 2000
- TriflusalDrugs, 1998
- Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatientsJournal of Internal Medicine, 1994
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- The bleeding severity index: Validation and comparison to other methods for classifying bleeding complications of medical therapyJournal of Clinical Epidemiology, 1989
- Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamoleThe American Journal of Cardiology, 1983